Alain Ruffion

The survival effect of prolactin on PC3 prostate cancer cells.

[Hormonal therapy in metastatic prostatic cancer].

Characterization of tumour necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in the adult human testis.

[Two indications for bilateral neuromodulation].

[Biopsy technique and biopsy schemes for a first series of prostatic biopsies].

[Spermatocytic seminoma. A clinicopathological and immunohistochemical study of 7 cases].

[Urinary incontinence in the adult. Diagnostic management].

[Contribution of fluorescence immunocytochemistry (uCyt+TM) in the postoperative surveillance of bladder cancer].

[Endocrine therapy for localized or locally advanced prostate cancer].

[Genito-scrotal pathology in the boy and in the man].

Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia.

[Prostatic cancer].

[Erectile dysfunction].

[Management in case of isolated precancerous lesions of the prostate (HG-PIN) discovered with biopsy].

[Is tumour grade applicable to finasteride-treated prostate cancer?].

[Types and mechanisms of 54 cases of kidney trauma in car drivers injured by road accident].

TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.

[New treatments for urinary incontinence in adults].

Ex vivo tumorectomy on transplanted kidney.

[PSA doubling time and method of calculation].

[Comparison of the response to I-PSS according to the mode of administration of the questionnaire: by the doctor or self-assessment by the patient].

[Well differentiated paratesticular liposarcoma in adults].

The epidemiology of trauma of the genitourinary system after traffic accidents: analysis of a register of over 43,000 victims.

Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer.

[Management of corpus cavernosum trauma].

What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity?

Discovery of a pituitary adenoma following a gonadotropin-releasing hormone agonist in a patient with prostate cancer.

[A modified IPSS score: value of a choice of qualitative answers].

[REMEEX: A possible treatment option in selected cases of sphincter incompetence].

[Chemical destruction of sacral nerve roots by alcohol injection for the treatment of overactive bladder].

[Value of urinary markers in the diagnosis and follow-up of urothelial bladder tumours].

Surgical principles of omentoplasty in urology.

The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines.

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Long-term outcome of forearm flee-flap phalloplasty in the treatment of transsexualism.

Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy.

Association between sarcoidosis and testicular carcinoma: a diagnostic pitfall.

Androgen inhibits the growth of carcinoma cell lines established from prostate cancer xenografts that escape androgen treatment.

Use of forearm free-flap phalloplasty in bladder exstrophy adults.

Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomy.

Urinary prostate cancer 3 test: toward the age of reason?

[Isolated testicular mass revealing a metastasis of prostate adenocarcinoma].

Quantitative loss of heterozygosity analysis for urothelial carcinoma detection and prognosis.

Treatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: a French retrospective multicentre study.

Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses.

Randomized, crossover study evaluating patient preference and the impact on quality of life of urisheaths vs absorbent products in incontinent men.

[Microsatellite markers and methylation of promoters of tumour suppressor genes in bladder cancer].

Urinary PCA3 score predicts prostate cancer multifocality.

[Atypical urothelial cells (AUC): A Bethesda-derived wording applicable to urinary cytopathology].

[Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience].

TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration.

Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.

Side effects of intradetrusor botulinum toxin injections on ejaculation and fertility in men with spinal cord injury: preliminary findings.

In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.

Can sacral neuromodulation improve minor incontinence symptoms in doubly incontinent patients successfully treated for major incontinence symptoms?

Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.

[Prostate-specific antigen use among men without prostate cancer in France (2008-2010)].

A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.

Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.

Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme.

Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.

The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.

Erratum to: Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival.

The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.

Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France.

Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall.

Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelialcarcinoma.

Reply: Four-hundredfold overestimation of biopsy mortality.

Reply: To PMID 22984785.

Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.

Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy.

Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.

Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.

Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours.

Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder.

PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy.

Prospective Study of Methods of Renal Function Evaluation in Patients With Neurogenic Bladder Dysfunction.

Surgical Outcomes and Patients' Satisfaction with Suprapubic Phalloplasty.

Microarray gene expression profiling and analysis of bladder cancer supports the sub classification of the T1 tumours in T1a and T1b stages.